4
Changes in Ownership
Nautilus Biotechnology, Inc. Filed Acc 0001543792-26-000002
Options or other derivatives
- Director acquired 45,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Posard Matthew L. Director | 2026-06-18 | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | D | ||
Loading xslF345X06/wk-form4_1782159249.xml…